ssy-8k_20210315.htm

8-K 1 ssy-8k_20210315.htm 8-K TRACE CAPEX 3.15.2021 ssy-8k_20210315.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities and Exchange Act of 1934

Date of Report (Date of earliest event reported) March 15, 2021

SUNLINK HEALTH SYSTEMS, INC.

(Exact Name of Registrant as Specified in Charter)


Ohio	1-12607	31-0621189
(State or other jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

900 Circle 75 Parkway, Suite 690, Atlanta, Georgia		30339
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (770) 933-7000

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered Pursuant to Section 12(b) of the Act:

Title of each Class

Trading Symbol

Name of each Exchange on which registered

Common Shares without par value

Preferred Share Purchase Rights

SSY

NYSE American, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1" = "1" "SGR/24391631.1" "" SGR/24391631.1

Item 8.01

Other Events

On March 15, 2021, SunLink Health Systems, Inc. announced that its wholly-owned subsidiary, Trace Regional Hospital (“Trace”), has implemented its Trace Forward Capital Plan (‘Plan”) totaling approximately $2 million to expand, upgrade and improve its physical plant, patient care, ancillary services and support areas. The Plan is being funded by Trace’s cash on hand.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits. The following exhibit is filed herewith:

Exhibit
NumberDescription

99.1	SunLink Health Systems, Inc. Press Release issued on March 15, 2021 regarding the Trace Forward Capital Plan.

1" = "1" "SGR/24391631.1" "" SGR/24391631.1

EXHIBIT INDEX


EXHIBIT NO.		DESCRIPTION

99.1		SunLink Health Systems, Inc. Press Release dated March 15, 2021 regarding the Trace Forward Capital Plan.

1" = "1" "SGR/24391631.1" "" SGR/24391631.1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.


SUNLINK HEALTH SYSTEMS, INC.

By:		/s/ Mark J. Stockslager
Name:		Mark J. Stockslager
Title:		Chief Financial Officer

Dated: March 17, 2021

1" = "1" "SGR/24391631.1" "" SGR/24391631.1

SEC Form 8-K filed by SunLink Health Systems, Inc.